EFFECT OF PIRFENIDONE IN PATIENTS WHO DEVELOPED PULMONARY FIBROSIS AFTER RECOVERING FROM EXPOSURE TO COVID-19.

Abstract

In this research paper, the researcher referred to the collection of random samples of varying ages recovering
from Covid-19 to determine the symptoms that appear on them immediately after recovery, and it was noticeable
on the majority of those who recovered from Covid-19 the occurrence of health problems associated with Covid19, which was clarified and concluded. Through those who recovered, the syndrome was prevalent in all patients
with Covid-19 after recovery, pulmonary fibrosis syndrome, where all the acute and serious symptoms indicated
acute shortness of breath And because pulmonary fibrosis syndrome and its acute symptoms cause death,
medical efforts were combined to develop drugs for respiratory crises and to analyze healthy ratios and
concentrations to determine the effective drugs that can be adopted as a course of treatment to get rid of
pulmonary fibrosis syndrome associated with Covid-19, and one of the most important drugs referred to is
Pirfenidone, which is known. The brand name Perfinex is what was used on randomized samples that were
selected to evaluate its effectiveness and the length of time that the drug can treat this syndrome.